These findings indicate that TP73-AS1 plays a critical role in lung cancer progression, and its expression level is closely associated with patient prognosis, suggesting that TP73-AS1 may serve as a novel potential target for the diagnosis and treatment of lung cancer. Here, TP73 is linked to lung carcinoma.